Australian Medication Safety Services
  • Home
  • Advisory Services & Analysis
  • Expert Clinical Guidance
  • Education
  • Medical Writing
  • Research Design & Supervision
  • Medicolegal Consulting
  • Comments
Select Page

From the archives – factors influencing serum clozapine concentrations

May 28, 2018

The RGH Pharmacy E-Bulletin was a popular electronic resource published online for more than a decade. With thousands of readers around the world, the E-Bulletin provided concise,
factual information on issues of current interest in therapeutics, drug safety and cost-effective use of medications. This post addresses factors influencing serum clozapine concentrations: http://www.sahealth.sa.gov.au/wps/wcm/connect/709ab6004d9966a48485a4aff22d4781/FactorsInfluencingClozapinePlasmaConcentrations-InfoSheet-mhda-nov2012.pdf?MOD=AJPERES

Recent Posts

  • Muscle symptoms don’t necessarily preclude further statin treatment
  • PPIs associated with increased risk of asthma in children
  • Anticoagulation and Covid19 infection
  • Semaglutide for weight loss
  • Involving pharmacists as prescribers improves prescription accuracy in hospitals

Archives

  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018

Copyright © 2025 Australian Medication Safety Services | PO Box 179, Glen Osmond, South Australia 5064 | Email: admin@medsafetyaustralia.com.au

Website Design